Search the Newsreel

Albemarle Corp. stock outperforms competitors on strong trading day

Albemarle Corp. (ALB) shares rose 1.67% to $130.48 on Thursday, outperforming the broader market. The S&P 500 Index gained 0.65% and the Dow Jones Industrial Average increased by 0.13% during the same trading session. This gain broke a two-day losing streak for the company's …

How Investors May Respond To LeMaitre Vascular (LMAT) Trimmed 2026 Outlook Despite Higher Q2 Sales

LeMaitre Vascular (LMAT) reported higher Q2 2026 sales and net income, but trimmed its full-year 2026 outlook due to currency headwinds, Middle East export delays, and cardiac allograft supply constraints. Despite these challenges, the company reinforced its growth narrative, though the revised guidance highlights …

Safe Harbor, Blackstone Comment on MarineMax Buy

Safe Harbor and its parent company Blackstone have commented on the recent acquisition of MarineMax, highlighting the complementary nature of the businesses and the goal to enhance services for boaters. Levin Capital, a major MarineMax shareholder, also praised the deal, emphasizing the significant premium …

Earnings call transcript: Bridgemarq beats Q2 2026 forecasts as stock rises

Bridgemarq cuts dividend to $0.05/share for tech investment

JPMorgan Chase & Co. Issues Pessimistic Forecast for Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price

GEHC or LMAT: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. There are plenty of strategies …

Braemar sells Key West resort for $190M amid shift to self-managed REIT

This story was originally published on Hotel Dive. To receive daily news and insights, subscribe to our free daily Hotel Dive newsletter. Dive Brief: Braemar Hotels & Resorts has sold the luxury Pier House Resort & Spa in Key West, Florida, to global investment …

Bridgemarq Real Estate Q2 2026 Earnings Call Transcript

J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $46

J.P. Morgan has reiterated its Buy rating on Olema Pharmaceuticals (OLMA.US) and set a price target of $46. This indicates a positive outlook from the firm regarding the company's future performance.

Albemarle (ALB) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations and Sustainability - Meredith BandyChief Executive Officer - Kent MastersChief Financial Officer - Neal SheoreyChief Operations Officer - Mark MummertChief Commercial Officer - …

Femasys Strengthens and Extends Global Patent Protection for FemBloc with First Issued Blended Polymer Patents

Femasys Inc. announced the issuance of new patents in the U.S. and internationally for the blended polymer component of its FemBloc non-surgical permanent birth control technology. These patents expand and strengthen the global intellectual property protection for FemBloc, complementing existing patents for its delivery …

LeMaitre Vascular remains a Buy despite 31% pullback; strong organic growth and record margins support outlook.

LeMaitre Vascular's stock experienced a 31% drop after missing Q2 2026 expectations due to currency issues, export blockages, and tissue shortages. However, the company demonstrates strong underlying demand with 10% organic sales growth and record-high margins, driven by its fastest-growing product, Artegraft. Despite the …

Sree Rayalaseema Hi-Strength Hypo Limited (SRHHYPOLTD.BO) stock price, news, quote and history

LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut (NASDAQ:LMAT)

Form 8K Olema Pharmaceuticals Inc For: 13 August By Investing.com

This article announces the filing of a Form 8K by Olema Pharmaceuticals Inc. on August 13. It includes the stock symbol OLMA and indicates a slight negative change in its price. The content provides a general news format from Investing.com with market data and …

Earnings Flash (BRE.TO) Bridgemarq Real Estate Services Inc. Reports Q2 Revenue C$97.5M

Cinemark Holdings Inc to Issue Quarterly Dividend of $0.09 (NYSE:CNK)

Cinemark Holdings Inc (NYSE:CNK) has declared a quarterly dividend of $0.09

MarineMax (NYSE:HZO) Downgraded by Northcoast Research to "Hold"

Northcoast Research downgraded MarineMax (NYSE:HZO) from a "strong buy" to a "hold" rating, joining several other analysts who have recently reduced their ratings for the company. The stock's consensus rating is now "Hold" with an average price target of $43.00. This downgrade follows MarineMax …

HC Wainwright Cuts Earnings Estimates for Hemab Therapeutics

HC Wainwright has lowered its FY2026 earnings per share estimate for Hemab Therapeutics to a loss of $3.19 per share, down from $3.12, while reaffirming a "Buy" rating and a $60 price target. The revision follows Hemab's recent quarterly EPS of $(0.80), which missed …

Bridgemarq Real Estate Services® Reports Second Quarter Financial Results

HC Wainwright Brokers Decrease Earnings Estimates for OLMA

Olema Oncology’s New CFO Brings More Than Two Decades in Biotech

Olema Oncology (Nasdaq: OLMA) has appointed Jason O’Byrne as its new Chief Financial Officer, bringing over two decades of finance leadership experience in the biotech and pharmaceutical sectors. This appointment comes as the company approaches pivotal data from its OPERA-01 study and prepares for …

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer

Olema Pharmaceuticals, Inc. (Olema Oncology) has appointed Jason O’Byrne, MBA, as its new Chief Financial Officer. O'Byrne brings over two decades of finance and operations leadership from high-growth biotechnology and pharmaceutical organizations, including roles at Vir Biotechnology, Caribou Biosciences, Audentes Therapeutics, and Genentech/Roche. His …

How Softening EPS Amid Rising Revenue At Emera (TSX:EMA) Has Changed Its Investment Story

Emera Incorporated recently reported its second-quarter 2026 results, showing increased revenue but softened earnings per share (EPS) due to higher costs and capital investments. This shift affects its investment narrative, which historically relied on regulated utility cash flows. The article suggests investors consider current …

Emami Realty Q1 Results: Net loss widens 28% YoY to ₹1,679 lakh

After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?

Albemarle reported strong Q2 results driven by higher lithium prices, leading to a 150% year-over-year profit growth. Morningstar maintains a $200 fair value estimate, rating the stock as moderately undervalued with a narrow economic moat due to its cost advantage in lithium and bromine …

Sree Rayalaseema Hi-Strength Hypo Q1 FY27 Results: Revenue Rs 210 Cr, PAT Rs 24 Cr and Key Highlights

Suyog Telematics Q1FY27 standalone net profit falls to ₹1,393.15 lakh

Aeorema Communications shares rise as group launches new buyback program

The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call

The Top 5 Analyst Questions From LeMaitre's Q2 Earnings Call LeMaitre's second quarter was marked by strong organic revenue gains, led by robust growth in its Artegraft line and continued expansion across Europe and Asia. However, the quarter fell short of Wall Street's revenue …

AlTi Global (ALTI) Stock Drifts As AUM Climbs Yet Losses Linger

AlTi Global's stock saw a slight increase after its Q2 2026 earnings report, with assets under management (AUM) rising to US$49.7 billion due to net inflows. Despite this growth in AUM, the company continues to report losses, with a basic loss per share of …

Sree Rayalaseema Hi-Strength Q1 Results: Net profit up 7.6% YoY to ₹251.8 crore

Cinemark Holdings Inc $CNK Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. significantly increased its stake in Cinemark Holdings Inc (NYSE:CNK) by 378.4% in the second quarter, now holding 117,150 shares valued at approximately $3.7 million. Several other institutional investors also expanded their positions. Cinemark shares rose 2.0% to $37.38 and reported …

Bridgemarq Real Estate Services Inc (BREUF) (Q2 2026) Earnings Call Highlights: Strategic Shift ... By GuruFocus

Eminence Minerals Expands Drilling at Brazilian Campo Grande Rare Earths Project